CONMED
CNMD
250 hedge funds and large institutions have $2.8B invested in CONMED in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 119 increasing their positions, 74 reducing their positions, and 56 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 74
0.08% less ownership
Funds ownership: 114.57% → 114.49% (-0.08%)
10% less funds holding
Funds holding: 279 → 250 (-29)
14% less capital invested
Capital invested by funds: $3.25B → $2.8B (-$450M)
41% less call options, than puts
Call options by funds: $19M | Put options by funds: $32.2M
45% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$38.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$24.8M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$19.7M |
| 4 |
BlackRock
New York
|
+$16.7M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$16.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$33.5M |
| 2 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$24.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$20.7M |
| 4 |
JG
Jefferies Group
New York
|
-$19.1M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$11.9M |
CNMD Hedge Fund Activity: Q3 2022 in Review
250 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2022, worth a combined $2.8B — down 14% from $3.25B a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of CNMD and 31 opened new positions — a net loss of 25 holders — while 74 trimmed existing stakes and 119 added.
The largest buyer was EARNEST Partners, adding an estimated $38.2M. The largest seller was Eagle Asset Management, cutting an estimated $33.5M.
- 250 institutional investors held CONMED (CNMD) as of Q3 2022, down from 279 in Q2 2022.
- Funds reported $2.8B of CONMED stock for Q3 2022, down 14% quarter-over-quarter.
- 31 funds opened new CONMED positions in Q3 2022 and 56 closed out, a net change of -25 holders.
- The largest CONMED buyer in Q3 2022 was EARNEST Partners, an estimated $38.2M added.
- The largest CONMED seller in Q3 2022 was Eagle Asset Management, an estimated $33.5M sold.
Based on aggregated 13F filings for Q3 2022.